Table 2.
|
RAI-L-ABL group |
C-Tx group |
T-Tx group |
|||
---|---|---|---|---|---|---|
Steps | Procedure | na | Procedure | na | Procedure | na |
Step 1 | Hemithyroidectomy | 37/37 | Hemithyroidectomy | 68/68 | T-Tx | 29/29 |
Step 2 | Thyroid lobe ablation (30–32 mCi 131I) | 37/37 | C-Tx | 68/73 | — | |
Step 3 | WBS (2 mCi 131I), Tg, TSH in hypothyroidism | 36/37 | WBS (2 mCi 131I), Tg, TSH in hypothyroidism | 58/68 | WBS (2 mCi 131I), Tg, TSH in hypothyroidism | 25/29 |
Step 4 | Remnant ablation (30–150 mCi 131I) | 15/37 | Remnant ablation (30–150 mCi 131I) | 58/68 | Remnant ablation (30–150 mCi 131I) | 12/29 |
Step 5 | Stimulated Tg | 12/37 | Stimulated Tg | 26/68 | Stimulated Tg | 12/29 |
Step 6 | Unstimulated Tg, clinical restaging at the end of follow-up | 37/37 | Unstimulated Tg, clinical restaging at the end of follow-up | 68/68 | Unstimulated Tg, clinical restaging at the end of follow-up | 29/29 |
Study procedures are described in their temporal sequence. All patients in all the RAI-L-ABL and C-Tx groups underwent Steps 1, 2, and 6. All patients in the T-Tx group underwent Steps 1 and 6.
Number of patients undergoing each step.
WBS, whole body scanning; Tg, thyroglobulin; TSH, thyroid-stimulating hormone.